Medical News

RSS

VIVUS to present data on Qnexa at ENDO meeting

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."

16 Jun 2010

Nuon Therapeutics NU1618 phase 2a study in hyperuricemia meets primary endpoint

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that a phase 2a study of NU1618, the company's lead program, met its primary endpoint of reduction in serum uric acid (sUA) levels in patients with hyperuricemia.

16 Jun 2010

Alameda Alliance for Health utilizes MedeAnalytics' analytic solutions to improve member outcomes, services

MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.

16 Jun 2010

Predictive Biosciences completes $25M Series C financing round

Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced the completion of a $25 million Series C round of growth capital financing. New investor ProQuest Investments led the round, joined by all current investors: Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.

16 Jun 2010

Covidien, Somanetics sign definitive merger agreement

Covidien plc and Somanetics Corporation today announced that they have signed a definitive merger agreement under which Covidien will acquire all of the outstanding shares of Somanetics Corporation for $25.00 per share in cash, for a total of $250 million, net of cash acquired.

16 Jun 2010

Report reveals increase in patients influence on success, failure of new drugs

Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.

16 Jun 2010

First Edition: June 16, 2010

Today's health policy headlines focus on the latest Senate developments regarding the Medicare 'doc fix' as well as continuing health reform implementation news.

16 Jun 2010

Differences in reproductive strategies drive individuals' views on recreational drugs: Study

Why is there so much disagreement about whether using recreational drugs is morally wrong? A University of Pennsylvania psychology study shows that the debate about drugs might really be about sex.

16 Jun 2010

Taste is in tongue of beholder when it comes to vodka

A UC researcher proposes that taste is in the tongue of the beholder when it comes to vodka.

16 Jun 2010

ESC, EACPR urges MEPs to vote in favour of traffic light system for food labelling

The European Society of Cardiology http://www.escardio.org/ and its branch, the European Association for Cardiovascular Prevention and Rehabilitation http://www.escardio.org/communities/EACPR/Pages/welcome.aspx, are joining forces with 12 other European Health and consumer communities to urge MEPs to vote in favour of a traffic light system for food labelling today.

16 Jun 2010

Benefits, quality gains of electronic referral management

Carefx Corporation, a leading provider of interoperable workflow solutions, announced today the availability of its new issue brief that outlines the benefits of electronic referral management – increased referral volume and revenue, enhanced clinical collaboration, simplified workflow and interoperability with health information exchange strategies.

16 Jun 2010

AVEO granted patents for tests to identify cancer patients likely to respond to tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the issuance of U.S. Patent Nos. 7,615,353, which issued in November 2009, and 7,736,861, which issued yesterday.

16 Jun 2010

Researchers study science and clinical treatment of FAS

It's long been known that alcohol use in pregnancy can lead to children with mental retardation and birth defects, but researchers who study fetal alcohol syndrome have not made definitive progress on preventing the disorder, detecting it early, or effectively treating it, say researchers from Georgetown University Medical Center.

16 Jun 2010

Injectable bone carries living stem cells

A team of researchers at the University of Nottingham have invented a new class of materials that can be injected by surgeons as a low-viscosity fluid into the body that, using body heat as the only trigger, converts into a tough porous material with mechanical properties that mimic human cancellous bone.

16 Jun 2010

Nordic Naturals introduces Omega Probiotic for optimal digestive and gastrointestinal health

Nordic Naturals, the industry leader in omega-3 fish oil, introduces Omega Probiotic, a synergistic blend of fish oil and live probiotic spores for optimal digestive and gastrointestinal health. The breakthrough formula combines two important nutrients that are commonly lacking in today's modern diet in one easy-to-take supplement that does not require refrigeration.

16 Jun 2010

Report on treatment trends in systemic lupus erythematosus

BioTrends is pleased to announce the upcoming publication of a new syndicated report, TreatmentTrends®: Systemic Lupus Erythematosus (SLE). This report will provide a comprehensive market overview of current and future treatment trends in SLE based on a primary research study fielded with 102 rheumatologists in the U.S. during the first week in June.

16 Jun 2010

Identification of key player in signaling pathway offers hope for new targeted melanoma therapies

Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.

16 Jun 2010

UNC researchers study why surgery happens less often in blacks with lung cancer

A new study led by UNC researchers that looks at newly diagnosed lung cancer patients and follows them from diagnosis forward is one of the first to give reasons why patients don't go to lung surgery and why surgery happens less often in blacks.

16 Jun 2010

Prevention, awareness of enlarged prostate can help save lives

We live in a country of excess where size often matters most. Supersize, grande, max, king size - but is bigger always better? Certainly not when it comes to male health and an enlarged prostate.

16 Jun 2010

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.

16 Jun 2010